232 related articles for article (PubMed ID: 1929760)
1. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
Davidson M; Kahn RS; Knott P; Kaminsky R; Cooper M; DuMont K; Apter S; Davis KL
Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited.
Volavka J; Douyon R; Convit A; Czobor P; Cooper TB
Arch Gen Psychiatry; 1992 Dec; 49(12):999-1000. PubMed ID: 1449388
[No Abstract] [Full Text] [Related]
4. Plasma homovanillic acid as a predictor of response to neuroleptics.
Davila R; Manero E; Zumarraga M; Andia I; Schweitzer JW; Friedhoff AJ
Arch Gen Psychiatry; 1988 Jun; 45(6):564-7. PubMed ID: 3377643
[TBL] [Abstract][Full Text] [Related]
5. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.
Duncan E; Wolkin A; Angrist B; Sanfilipo M; Wieland S; Cooper TB; Rotrosen J
Biol Psychiatry; 1993 Oct; 34(8):523-8. PubMed ID: 8274579
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients.
Suzuki E; Kanba S; Nibuya M; Adachi S; Sekiya U; Shintani F; Kinoshita N; Yagi G; Asai M
Biol Psychiatry; 1994 Nov; 36(10):654-61. PubMed ID: 7880934
[TBL] [Abstract][Full Text] [Related]
7. Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.
Suzuki E; Kanba S; Koshikawa H; Nibuya M; Yagi G; Asai M
J Psychiatry Neurosci; 1996 May; 21(3):167-71. PubMed ID: 8935328
[TBL] [Abstract][Full Text] [Related]
8. Correlates of rapid neuroleptic response in male patients with schizophrenia.
Petrie EC; Faustman WO; Moses JA; Lombrozo L; Csernansky JG
Psychiatry Res; 1990 Aug; 33(2):171-7. PubMed ID: 2243894
[TBL] [Abstract][Full Text] [Related]
9. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
Dávila R; Zumárraga M; Basterreche N; Arrúe A; Anguiano JB
Psychiatry Res; 2007 May; 151(1-2):163-8. PubMed ID: 17434602
[TBL] [Abstract][Full Text] [Related]
10. Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.
Davidson M; Kahn RS; Stern RG; Hirschowitz J; Apter S; Knott P; Davis KL
Psychiatry Res; 1993 Feb; 46(2):151-63. PubMed ID: 8483974
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
Pickar D; Labarca R; Doran AR; Wolkowitz OM; Roy A; Breier A; Linnoila M; Paul SM
Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170
[TBL] [Abstract][Full Text] [Related]
12. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
[TBL] [Abstract][Full Text] [Related]
13. Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms.
Khan RS; Amin F; Powchik P; Knott P; Goldstein M; Apter S; Kerman B; Jaff S; Davidson M
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):879-84. PubMed ID: 1980541
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients.
Pickar D; Labarca R; Linnoila M; Roy A; Hommer D; Everett D; Paul SM
Science; 1984 Aug; 225(4665):954-7. PubMed ID: 6474162
[TBL] [Abstract][Full Text] [Related]
15. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
Davidson M; Davis KL
Arch Gen Psychiatry; 1988 Jun; 45(6):561-3. PubMed ID: 3377642
[TBL] [Abstract][Full Text] [Related]
16. Plasma homovanillic acid and treatment response in a large group of schizophrenic patients.
Chang WH; Hwu HG; Chen TY; Lin SK; Lung FW; Chen H; Lin WL; Hu WH; Lin HN; Chien CP
Schizophr Res; 1993 Oct; 10(3):259-65. PubMed ID: 8260444
[TBL] [Abstract][Full Text] [Related]
17. Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects.
Magliozzi JR; Doran AR; Gietzen DW; Olson AM; Maclin EL; Tuason VB
Psychiatry Res; 1993 May; 47(2):141-9. PubMed ID: 8341767
[TBL] [Abstract][Full Text] [Related]
18. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
Newcomer JW; Riney SJ; Vinogradov S; Csernansky JG
Psychiatry Res; 1992 Mar; 41(3):191-202. PubMed ID: 1594706
[TBL] [Abstract][Full Text] [Related]
19. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
Davidson M; Losonczy MF; Mohs RC; Lesser JC; Powchik P; Freed LB; Davis BM; Mykytyn VV; Davis KL
Neuropsychopharmacology; 1987 Dec; 1(1):17-23. PubMed ID: 3509064
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of haloperidol on negative symptoms in drug-naive schizophrenic patients: effects on plasma homovanillic acid.
Labarca R; Silva H; Jerez S; Ruiz A; Forray MI; Gysling K; Andres ME; Bustos G; Castillo Y; Hono J
Schizophr Res; 1993 Mar; 9(1):29-34. PubMed ID: 8461269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
